Revenue

Revenue Recognized from Contract Liabilities

Thermo Fisher Scientific Revenue Recognized from Contract Liabilities decreased by 5.1% to $1.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $1.36B to $1.29B. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionRevenue
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026

How to read this metric

Consistent recognition of deferred revenue indicates a healthy pipeline of service delivery and stable business operations.

Detailed definition

This metric tracks the portion of revenue recognized during the period that was previously recorded as deferred revenue...

Peer comparison

Commonly analyzed for SaaS and subscription-based business models.

Metric ID: isrg_contract_liability_revenue_recognized

Historical Data

13 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q1 '26
Value$370.00M$170.00M$1.28B$710.00M$340.00M$1.30B$680.00M$350.00M$1.32B$670.00M$360.00M$1.36B$1.29B
QoQ Change-54.1%+652.9%-44.5%-52.1%+282.4%-47.7%-48.5%+277.1%-49.2%-46.3%+277.8%-5.1%
YoY Change+91.9%+100.0%+1.6%-4.2%+2.9%+1.5%-1.5%+2.9%+3.0%-5.1%
Range$170.00M$1.36B
CAGR+51.6%
Avg YoY Growth+19.3%
Median YoY Growth+2.2%

Revenue Recognized from Contract Liabilities at Other Companies

Frequently Asked Questions

What is Thermo Fisher Scientific's revenue recognized from contract liabilities?
Thermo Fisher Scientific (TMO) reported revenue recognized from contract liabilities of $1.29B in Q1 2026.
How has Thermo Fisher Scientific's revenue recognized from contract liabilities changed year-over-year?
Thermo Fisher Scientific's revenue recognized from contract liabilities decreased by 5.1% year-over-year, from $1.36B to $1.29B.
What does revenue recognized from contract liabilities mean?
Revenue recognized this period that was previously held as deferred revenue.